Truvestments Capital LLC Adma Biologics, Inc. Transaction History
Truvestments Capital LLC
- $376 Million
- Q4 2024
A detailed history of Truvestments Capital LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Truvestments Capital LLC holds 517 shares of ADMA stock, worth $8,220. This represents 0.0% of its overall portfolio holdings.
Number of Shares
517
Previous 186
177.96%
Holding current value
$8,220
Previous $3,000
166.67%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ADMA
# of Institutions
334Shares Held
188MCall Options Held
1.52MPut Options Held
756K-
Black Rock Inc. New York, NY18.6MShares$296 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$289 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$236 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$180 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$88 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.12B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...